show episodes
 
Welcome to Conversations in Drug Development, brought to you by the team at Boyds for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development. This podcast series features candid conversations from the expert team at Boyds, who are at the forefront of cutting-edge science and drug development in the pharmaceutical and biotechnology sector.
  continue reading
 
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
  continue reading
 
Artwork

1
Speaking of Mol Bio

Thermo Fisher Scientific

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
Speaking of Mol Bio, a podcast series from Thermo Fisher Scientific, discusses trending applications in science and the molecular biology aspects of those applications. Our host delves in to deep discussion with CEOs, R&D scientists, researchers, and key opinion leaders across the globe. Speaking of Mol Bio helps scientific curious people - from all scientific and non-scientific backgrounds - understand how modern molecular biology applications can help push the boundaries in medicine, scien ...
  continue reading
 
Artwork

1
Translating Proteomics

Nautilus Biotechnology

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
‘Translating Proteomics’ explores the science of proteomics and its growing impact on biological research, biomarker discovery, drug development, food and energy security, and a range of other timely topics. Hosts Parag Mallick Ph.D. and Andreas Huhmer Ph.D. of Nautilus Biotechnology aim to share their perspectives on important issues in proteomics, deepen your love of science, and prompt you to question assumptions about what may be possible.
  continue reading
 
Welcome to P4A Let’s Talk Rare, a monthly podcast highlighting the most important developments in the world of rare diseases orphan drug, cell and gene therapy, hosted by Georgie Rack and Owen Bryant of Partners For Access. To find out more about Partners For Access and our commitment to sustainable orphan drug access for patients with high unmet need, visit partners4access.com
  continue reading
 
Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MA ...
  continue reading
 
Artwork

1
Sounds of Science

Charles River

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
Sounds of Science is a monthly podcast about beginnings: how a molecule becomes a drug, how a rodent elucidates a disease pathway, how a horseshoe crab morphs into an infection fighter. The podcast is produced by Eureka, the scientific blog of Charles River, a contract research organization for drug discovery and development. Tune in and begin the journey.
  continue reading
 
Artwork
 
The Recovery Radio Network brings you twelve step speakers and workshops designed for recovering individuals and the people who support them. The speakers share their personal experiences of recovery on the topics of alcoholism, co-dependency, and drug addiction, while our workshops are aimed at helping recovering individuals develop a better understand of twelve step programs.
  continue reading
 
Artwork

1
MPR Weekly Dose

MPR Weekly Dose

icon
Unsubscribe
icon
Unsubscribe
Monthly+
 
Each week the MPR team brings you the top stories from the world of medicine and pharma in a matter of minutes. With 35 years of publishing drug information behind us, you can rely on MPR to provide accurate and up-to-date news.
  continue reading
 
Artwork

1
The Stack Overflow Podcast

The Stack Overflow Podcast

icon
Unsubscribe
icon
Unsubscribe
Weekly+
 
For more than a dozen years, the Stack Overflow Podcast has been exploring what it means to be a software developer and how the art and practice of programming is changing our world. From Rails to React, from Java to Node.js, join the Stack home team for conversations with fascinating guests to help you understand how technology is made and where it’s headed.
  continue reading
 
The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.
  continue reading
 
Artwork

1
Transformation in Trials

Sam Parnell & Ivanna Rosendal

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
A podcast about the transformations in clinical trial. As life science companies are pressured to deliver novel drugs faster, data, processes, applications, roles and change itself is changing. We speak to people in the industry that experience these transformations up close and make sense of how the pressure can become a catalyst for transformation.
  continue reading
 
Artwork

1
The Uromigos

The Uromigos

icon
Unsubscribe
icon
Unsubscribe
Weekly+
 
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
  continue reading
 
Artwork
 
One-on-one with medical innovators Breakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma’s dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. BioWorld tracks key events in the fast-moving sector every business day. Now, the BioWorld Insider podcast lets you hear directly from the movers and shakers whose collec ...
  continue reading
 
Artwork

1
PharmaTalkRadio

Pharma Talk Radio

icon
Unsubscribe
icon
Unsubscribe
Weekly
 
PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership ...
  continue reading
 
Artwork

1
PEP Talks ISPEP

Emma Sutcliffe

icon
Unsubscribe
icon
Unsubscribe
Monthly+
 
PEP Talks from ISPEP The role of a patient engagement professional can be ... lonely, rewarding, frustrating, demanding. All of these things! It is a challenge advocating for people living with chronic, rare, sometimes life-threatening conditions. These short PEP Talks are there for you when you need a boost from a fellow professional. Brought to you by ISPEP -- the professional home for all patient engagement experts.
  continue reading
 
Are you interested in your health or the health of a loved one? Mike Dilke speaks to experts in all kinds of health related fields covering topics such as smoking, vaping, medicines derived from cannabis, mental health, sleep, exercise, joint pain, back pain, nutrition and many others. Keep up with important health news and issues by listening to the Relaxback UK Show.
  continue reading
 
Artwork

1
Disruptive CEO Nation

Allison Summers

icon
Unsubscribe
icon
Unsubscribe
Monthly+
 
EXECUTIVE COACH + GLOBAL BUSINESS LEADER ADVISOR. SPEAKER. AUTHOR. GUIDING SMART PEOPLE TO GROW INFLUENCE & CREATE OPPORTUNITIES Over 30 years, I have had the opportunity to work with fantastic organizations, impressive individuals and key industry leaders across six continents. Sitting in the corner office in both corporate and non-profit environments, I’ve attained, delivered and coached success in both the C-Suite and international board rooms. My diverse experience has provided cross-cul ...
  continue reading
 
Hello Combi-Nation! Our industry fee complicated sometimes. Drugs, devices, clinical trials, submissions, sterilization validation, design control, risk management, market access reimbursement, the list goes on. My name is Subhi Saadeh. I've spent over a decade in medical device, pharma, and combination product development. My goal is mastery, so this podcast is to ask questions I have to people who may have the answers. Whether you're background is Pharma, Device or both, I invite you to li ...
  continue reading
 
Welcome to the MedEvidence! podcast, hosted by Dr. Michael Koren. MedEvidence, where we help you navigate the real truth behind medical research with both a clinical and research perspective. In this podcast, we will discuss with physicians with extensive experience in patient care and research. How do you know that something works? In medicine, we conduct clinical trials to see if things work! Now, let's get to the Truth Behind the Data. Contact us at www.MedEvidence.com
  continue reading
 
Artwork

1
Laborastories | presented by ADLM

Association for Diagnostics & Laboratory Medicine (formerly AACC)

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
ADLM is pleased to present Laborastories: The Podcast. In this new series, ADLM President Dr. Anthony Killeen talks with experts in laboratory medicine to learn more about the people behind clinical laboratory testing and explore both the current issues they are facing and the many ways their work impacts patient lives. Remember – every laboratorian has a story.
  continue reading
 
Artwork
 
Inside 340B Report is your exclusive, behind-the-scenes window into the latest news and developments in the 340B drug pricing program, straight from the journalists at 340B Report. Each episode, published twice a month, brings listeners inside 340B Report’s newsroom for a candid, insider’s perspective on the evolving drug pricing policy landscape from the journalists who cover it daily.
  continue reading
 
Delve into the frontiers of cutting-edge brain science with ‘Research Renaissance’ a podcast presented by the Karen Toffler Charitable Trust. Join us on a journey of discovery with a diverse lineup of guests, including early career researchers undertaking groundbreaking studies. Hear their insights alongside voices from investment communities, policymakers, and research institutions. Collectively we explore the complexities of neurological diseases, their root causes, potential treatments, a ...
  continue reading
 
Artwork
 
The Alpha Hour is where real conversations meet real growth. Hosted by Paj Mohager, this show explores what it means to level up in life through candid chats with leaders, experts, and everyday achievers. No fluff—just authentic stories, practical insights, and down-to-earth advice to help you unlock your potential. Whether you’re aiming for personal development or professional success, The Alpha Hour gives you the tools and mindset to make it happen. Tune in, get inspired, and start your jo ...
  continue reading
 
Artwork
 
FDA CMC regulations and guidance simplified through examination, real life experiences and risk-based advice. This podcast hopes to educate sponsors and individuals on agency related regulatory CMC matters. We will focus on the critical CMC issues and build programs that enhance drug development. CMC topics will include Regulatory Starting Materials, API and Drug Product Process, Formulation Development, Supply Chains, Analytical Controls. Advocating and interpreting CMC Strategy, directing ...
  continue reading
 
Artwork

1
Med X Health

MedX Health

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
This podcast discusses MedX Health, listed on the TSX-V under the symbol MDX, whose mission is to develop and implement non-invasive, practical, drug-free and cost-effective skin analysis and assessment systems for use by trained medical professionals, as well as light therapeutics and imaging systems that can help to save lives and enhance patients’ quality of life and improve standards of care.
  continue reading
 
Artwork

1
In Good Company with Nicolai Tangen

Norges Bank Investment Management

icon
Unsubscribe
icon
Unsubscribe
Weekly+
 
The CEO of the largest single investor in the world, Norges Bank Investment Management, interviews leaders of some of the largest companies in the world. You will get to know the leader, their strategy, leadership principles, and much more. Hosted on Acast. See acast.com/privacy for more information.
  continue reading
 
Artwork

1
The Michael J. Fox Foundation Parkinson's Podcast

The Michael J. Fox Foundation for Parkinson’s Research

icon
Unsubscribe
icon
Unsubscribe
Monthly+
 
Subscribe for coverage and analysis of current neurology/brain research, patient and caregiver profiles, drug development strategy, pioneering nonprofit management and other topics of interest in a wide-ranging series of conversations that include the voices of those affected by Parkinson's as well as clinicians.
  continue reading
 
Artwork
 
The Heart & Science of Leadership" podcast, co-hosted by Dr. Paulie and A.J. Rinaldi, combines their diverse backgrounds in leadership to offer a comprehensive view on what it takes to lead effectively, no matter your position—be it executive, teacher, manager, principal, supervisor, or coach. Together, they explore the balance between the human side of leadership and evidence-based practices, providing listeners with practical tools, real-life stories, and actionable strategies. Whether you ...
  continue reading
 
Artwork
 
The AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI. Each week, Emerj AI Research CEO Daniel Faggella and team interview top AI executives from Fortune 2000 firms and unicorn startups - uncovering trends, use-cases, and best practices for practical AI adoption. Visit our advertising page to learn more about reaching our executive audience of Fortune 2000 AI adopters: https://emerj.com/advertise
  continue reading
 
Presented by Kymanox, Life Science Solutions is dedicated to accelerating understanding and advancing expertise in the life sciences industry. Focused on bringing industry insights to light, our podcast offers a platform where regulatory, scientific, and engineering experts share practical knowledge on overcoming the challenges of product development and commercialization. Episodes equip listeners with the latest on regulatory updates, market trends, cutting-edge technology, and more. Join u ...
  continue reading
 
Artwork

1
Future Labs

João Ribas

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
Welcome to Future Labs, a podcast series featuring today's leaders on tomorrow's future. We speak to experts around the globe about their role in changing the world for the better. Stay tunned for the upcoming Season 2!
  continue reading
 
Artwork

1
OC24 Podcast

Global Initiative Against Transnational Organized Crime

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
Experts, analysts and scholars from around the world came together for the 24 Hour Conference on Global Organized Crime, to discuss the most fascinating research into organized crime.
  continue reading
 
Loading …
show series
 
In the latest episode of Let's Talk Rare, Owen Bryant & Georgie Rack delve into the world of drug development in rare diseases. They are joined by the brilliant Rob Freishtat, president of Uncommon Cures. Rob brings unique insights on who the key stakeholder are in developing drugs and the many ways that we can bring them together in order to impro…
  continue reading
 
Send us a text Rob Freistat, President of Uncommon Cures, discusses how clinical trials are transforming to accelerate drug development and ensure patients receive treatments faster, particularly in the rare disease space. • Current market uncertainty and investment challenges in biotech, especially for rare disease research • Approximately two-thi…
  continue reading
 
Pfizer ends danuglipron clinical program for obesity; FDA warns about counterfeit Ozempic; daily pill shows promise in reducing HbA1c; mavacamten misses in nonobstructive HCM trial and the FDA clears smart belt device reduce fall injury.
  continue reading
 
00:00:00 - Surf's Up: Season 6 Episode 5 Host Roger Green briefly describes this episode’s three sections and introduces Roundtable guests. The Roundtable panel shares groundbreakers. 00:10:39 - Roundtable: A Deep Dive Into Drug Development, Part One The opening portion of this month's roundtable centers around two issues: exciting data for FGF-21s…
  continue reading
 
Send us a text On this Monday Morning Minute, Dr. Michael Koren draws parallels between the NCAA Final Four basketball tournament and the clinical research process. He explains that in medicine, researchers start with literally 10,000 potential molecules, which get whittled down to only three or four medications to be tested in big, phase III clini…
  continue reading
 
In this episode of PEP Talks, Emma interviews Dr. David Gillen, the Chief Medical Officer of Norgine, discussing the evolution and importance of patient engagement in the pharmaceutical industry. Reflecting on their first meeting 16 years ago, they explore how patient demands and advocacy have shaped industry practices. Dr. Gillen emphasises the cr…
  continue reading
 
In this episode, 340B Report Publisher & CEO Ted Slafsky joins Associate Editors and Senior Writers Shannon Young and Will Newton and National Correspondent Bella Czajkowski to break down the latest developments in the 340B space. The team discusses Senate HELP Committee Chair Bill Cassidy’s (R-La.) high-profile report on the 340B program, an execu…
  continue reading
 
View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter’s Weekly Newsletter Susan Desmond-Hellmann is a physician and scientist whose remarkable career has spanned clinical medicine, oncology, biotech innovation, and global health leadership. In this episode, Susan shares insights from her jou…
  continue reading
 
00:00:00 Surf's Up, Season 6, Episode 6. On April 23, 2024, our colleague and co-founder, Stephen Harrison, passed away suddenly. This week, Surfing the MASH Tsunami remembers Stephen with two of his closest associates and continues our annual MASH Drug Development roundtable held in his honor. 00:00:04:24 - A Deep Dive into Drug Development, Part …
  continue reading
 
The FDA issues alert regarding a compounded topical finasteride; plant-based alkaloid shows improvement for smoking cessations; potential new treatment option for GERD; and the CDC’s Advisory Committee on Immunization Practices make new recommendations.
  continue reading
 
Paul Dhaliwal is the founder and CEO of CodeConductor. Priya Joseph is the AI field CEO at DDN. Lizzie Siegle is a developer advocate at Cloudflare. Erin Mikail Staples is a developer experience engineer at Galileo. This episode was recorded at HumanX last month. Next year’s event will be April 6-9, 2026 in San Francisco. Register today!…
  continue reading
 
We've curated a special 10-minute version of the podcast for those in a hurry. Here you can listen to the full episode: https://podcasts.apple.com/no/podcast/kenneth-rogoff-tariff-impacts-the-dollars-future/id1614211565?i=1000704545192&l=nb What challenges lie ahead for the global economy in an era of rising tariffs and geopolitical tension? In thi…
  continue reading
 
This weekend’s Newsmaker, Indiana University hepatologist and key opinion leader Naga Chalasani, joins Roger Green to discuss Early Experience with Resmetirom To Treat Metabolic-Associated Steatohepatitis with Fibrosis in a Real-World Setting, an article his group published recently in Hepatology Communications. He shares highlights from the paper …
  continue reading
 
This week’s expert, Hepatologist and Key Opinion Leader Scott Friedman, joins Roger to discuss advances in acceptance of gene therapy and knowledge in other areas of basic liver science. When discussing science, he pays particular attention to findings on the diversity of stellate cells and his interest in CAR-T as a therapy for liver disease. This…
  continue reading
 
They also discuss: Lloyds Banking Group's multi-year journey to drive simplification and standardization, reduce cognitive load & improve engineering efficiency, and enhance developer happiness. Challenges engineering teams face today, along with the cultural shifts in regulatory environments. Episode notes: Connect with Hilary Lanham and Tom Kelk.…
  continue reading
 
Life with Parkinson’s comes with a vast range of emotions, wherever you are in your disease journey. Shock, grief, optimism, fear, denial, hope, humor and more can all be a part of the emotional landscape for people living with the disease and their loved ones. Tune into audio from this special edition Third Thursdays Webinar to listen to our panel…
  continue reading
 
In this special episode recorded live at CED Venture Connect, host Chris Adkins sits down with Dave Ousterout, Co-Founder and General Partner at CapeFear Biocapital. Drawing from his unique journey as both a biotech entrepreneur and now a venture capital investor, Dave shares what it really takes to stand out in the early-stage life sciences space.…
  continue reading
 
In this episode of Let's Combinate, host Subhi Saadeh is joined by Aaron Snyder, the creator of Quality Systems Explained and a seasoned consultant in regulated quality systems. The discussion revolves around the critical role of documentation in quality systems, which serves as the backbone of compliance. Key topics include the hierarchy of regula…
  continue reading
 
In this episode, Ayesha spoke with Dr. Shaharyar Khan, co-founder and chief scientific officer at Rivus Pharmaceuticals. Rivus is developing a new class of investigational medicines called controlled metabolic accelerators (CMAs) for cardiometabolic diseases like diabetes, heart disease, heart failure and MASH by targeting obesity. Dr. Khan is an e…
  continue reading
 
We always say your best business partner can be in the most surprising places. Today, we discuss why holding a global mindset and helping new companies with their first funding boost, regardless of location, makes for a healthier business ecosystem. Jenny Fielding, the co-founder and managing partner of Everywhere Ventures, is a big believer in the…
  continue reading
 
Send us a text Dr. Michael Koren sits down with Dr. Murali Ramaswamy to explore the concept of Research as a Care Option. They compare this with the misconception of research as a treatment option to reveal how clinical trials provide structured environments that often lead to better health outcomes regardless of the specific intervention. They deb…
  continue reading
 
What challenges lie ahead for the global economy in an era of rising tariffs and geopolitical tension? In this episode, Nicolai Tangen speaks with Kenneth Rogoff, renowned economist and co-author of the seminal book "This Time Is Different," about the shifting economic landscape. They discuss the potential impacts of Trump's tariff policies, the fu…
  continue reading
 
This conversation is the opening segment of SurfingMASH's April discussion, in memory of Stephen A. Harrison, on drug development. In addition to co-hosts Jörn Schattenberg, Louise Campbell and Roger Green, panelists include hepatologists and key opinion leaders Sven Francque and Naim Alkhouri. This opening discussion focuses on exciting advances i…
  continue reading
 
Loading …

Quick Reference Guide

Listen to this show while you explore
Play